they inhibited 75% of the thymidine uptake, when taken from PM cultures with as little as 0.5%0 foetal bovine serum. Further, it was found that sera from various species could produce this macrophage activation. The supernatant of 72 h cultured PM contained a cytostatic factor (CF) which could inhibit 50-75% of the thymidine incorporation in equal number of HPM cells. CF was found to be thermostable and dialysable.
These findings suggest that some normal serum components could substitute in vitro for the in vivo activation of PM. Macrophages from mice sensitized to one antigen become nonspecifically cytotoxic to tumour cells after meeting the same antigen again (Evans and Alexander, Nature, Lond., 1972, 236, 168) . This transformation was termed macrophage activation. Where a condition of chronic infection has become established, persistence of the infecting antigen can lead to the presence of activated macrophages (Hibbs, Lambert and Remmington, J. infect. Dis., 1971, 124, 587) In a family of 5 girls, 3 of whom have Hodgkin's disease, pathogenetic possibilities were studied, i.e. HL-A typing, chromosomes, detailed blood group analysis, humoral antibody (immunoglobulins, serum protein electrophoresis), cell mediated immunity (PPD, DNCB, LTT and MLC), viral studies (Epstein-Barr, other herpesviruses, CMV) Australia antigen.
The major abnormality was a defect of cell mediated immunity detected in both parents and the 5 girls as evidenced by very poor in vitro lymphocyte blastogenesis with PHA in all 7. The fourth sister (recent infectious mononucleosis), and the mother, were anergic to PPD and DNCB while the father and fifth sister (recurrent herpes labialis) both had 4+ DNCB, reaction. In addition, the mother had an M band on serum protein electrophoresis.
Our findings suggest that a familial cell mediated immune depletion is providing a milieu wherein viral infection may manifest itself as Hodgkin's disease. One patient with malignant melanoma showed regression of more than 70 B.C.G. injected subcutaneous metastases: the rate at which new deposits developed declined and there was only minimal spread to internal organs. Intra-tumoral B.C.G. was followed by regression and eventual sloughing of approximately 90% of an extensive fungating tumour in a patient with local recurrence of breast cancer in the mastectomy scar. Local reaction to intratumoral B.C.G., without retardation in the progression of the disease, was observed in a patient with malignant melanoma while prolongation of survival was noted in another patient who had a large solitary lung metastasis. There was no detectable response to B.C.G. in the remaining 3 cases.
SOME ASPECTS OF THE USE
Pyrexia, lassitude and anorexia occurred as transient side-effects of B.C.G. therapy in 3 patients. One patient experienced a severe generalized B.C.G. infection.
